Related Experiment Video
Updated: Jun 25, 2026
06:43
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Pediatric gastrointestinal stromal tumors
Alberto S Pappo1, Katherine A Janeway
1Department of Pediatrics, Texas Children's Cancer Center, 6621 Fannin Street, CC1510.00, Houston, TX 77030, USA. aspappo@txccc.org
Hematology/Oncology Clinics of North America
|March 3, 2009
Summary
Pediatric gastrointestinal stromal tumors (GISTs) are rare but distinct from adult GISTs. This review covers their unique biology, clinical behavior, and management in patients 18 years or younger.
Area of Science:
- Pediatric oncology
- Gastrointestinal pathology
- Molecular diagnostics
Background:
- Gastrointestinal stromal tumors (GISTs) are rare in children, with diagnosis typically occurring before age 18.
- Increased recognition of adult GISTs has improved awareness of pediatric GISTs.
- Pediatric GISTs exhibit unique biological and clinical characteristics, necessitating separate consideration.
Purpose of the Study:
- To review the distinct clinical features of pediatric GISTs.
- To explore the molecular biology underlying GISTs in young patients.
- To outline current clinical management strategies for pediatric GISTs.
Main Methods:
- Literature review of pediatric GIST cases.
- Analysis of clinical presentation and outcomes.
- Examination of molecular alterations in pediatric GISTs.
Main Results:
- Pediatric GISTs present differently and have distinct molecular profiles compared to adult GISTs.
- Specific genetic mutations are associated with pediatric GISTs.
- Management strategies are evolving based on these unique features.
Conclusions:
- Pediatric GISTs represent a unique entity within GISTs.
- Understanding the distinct biology and clinical behavior is crucial for effective management.
- Further research is needed to optimize treatment protocols for this rare population.
